Zurich Cantonal Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Zurich Cantonal Bank’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,568	Closed	-$99K	–	2613
2018 Q3	$99K	Hold	5,568	–	–	﹤0.01%	1715
2018 Q2	$77K	Buy	+5,568	New	+$66.1K	﹤0.01%	1833
2014 Q1	–	Sell	-50,000	Closed	-$535K	–	1004
2013 Q4	$535K	Hold	50,000	–	–	0.02%	613
2013 Q3	$667K	Buy	+50,000	New	+$790K	0.02%	543

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Zurich Cantonal Bank's ECYT Position: Q4 2018 in Review

Zurich Cantonal Bank sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 5,568 shares — an estimated $99K sold.

Zurich Cantonal Bank first reported a position in ECYT in Q3 2013 and held it in 4 quarters. The position peaked at $667K in Q3 2013. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Zurich Cantonal Bank reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Zurich Cantonal Bank sold 5,568 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $99K.
Zurich Cantonal Bank first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 4 quarters.
Zurich Cantonal Bank's Endocyte, Inc. Common Stock position peaked at $667K in Q3 2013.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Zurich Cantonal Bank's 13F filing for Q4 2018, filed 25 Jan 2019.